← SynDRA

TIVANTINIB

SynDRA canonical compound SYN0030080 — structure-anchored drug synonym record

All known targets

• MET

Mechanisms of action (all sources)

• tyrosine kinase inhibitor
• MET INHIBITOR
• Hepatocyte growth factor receptor inhibitor

Cross-references

• PubChem CID: 11494412
• ChEMBL: CHEMBL2103882
• DrugBank: DB12200
• ChEBI: 91398
• KEGG: D10173
• PDB: TIV
• Wikipedia: Tivantinib
• TTD: D0ZI1F
• LINCS BRD: BRD-K33379087

Synonyms

• ARQ-197
• ARQ 197
• ARQ197
• Tivantinib (ARQ-197)
• (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
• UNII-PJ4H73IL17
• PJ4H73IL17
• (3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
• Tivantinib [USAN:INN]
• ARQ 197, Tivantinib
• ARQ 197 (Tivantinib)
• cc-86
• SCHEMBL44944
• Tivantinib (JAN/USAN/INN)
• GTPL7948
• CHEMBL2103882
• CHEBI:91398
• QCR-102
• Tivantinib (ARQ 197)
• rel-(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione
• Tivantinib [INN]
• Tivantinib; ARQ197
• TIVANTINIB [MI]
• TIVANTINIB [JAN]
• TIVANTINIB [USAN]
• TIVANTINIB [WHO-DD]
• DTXSID60920316
• ARQ-197,Tivantinib, ARQ197
• ARQ197; ARQ-197;Tivantinib
• BCPP000042
• BCP02529
• EX-A2169
• CAS:905854-02-6;Tivantinib
• BDBM50146168
• MFCD11977596
• NSC758242
• NSC800951
• s2753